Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
95.40    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (0.211%)
Market Cap: £351.49m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Board Committee Changes

24 Oct 2019 07:15

RNS Number : 9101Q
C&C Group Plc
24 October 2019
Β 

C&C Group plc

('C&C' or the 'Group')

Board Committees Changes

Β 

C&C Group plc announces the following changes to the membership of its Board Committees with effect from 24 October 2019:

Β·; Jim Clerkin, Non-Executive Director, will replace Vincent Crowley, Senior Independent Director, as a member of the Remuneration Committee.

Β·; Helen Pitcher, Non-Executive Director, will be appointed as a member of the Nomination Committee.

Therefore, as from 24 October, the composition of the Group's Board Committees will be as follows:

Β·; Audit Committee - Emer Finnan (Chairman), Vincent Crowley and Jim Thompson.

Β·; Remuneration Committee - Helen Pitcher (Chairman), Jill Caseberry and Jim Clerkin.

Β·; Nomination Committee - Stewart Gilliland (Chairman), Vincent Crowley, Emer Finnan and Helen Pitcher.

This announcement is made in accordance with Rule 9.6.11 (3) of the FCA Listing Rules.

- END -

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

Β·; C&C Group's portfolio of owned/exclusive brands include: Bulmers, the leading Irish cider brand; Tennent's, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of fast-growing, super-premium and craft ciders and beers, such as Heverlee, Menabrea and Orchard Pig.

Β·; C&C Group has own brand and contract manufacturing/packing operations in Co. Tipperary, Ireland; Glasgow, Scotland; and Vermont, United States, where it manufactures Woodchuck, a leading craft cider brand in the United States.

Β·; C&C is the No.#1 drinks distributor to the UK and Ireland hospitality sectors. Operating under the Matthew Clark, Bibendum, Tennent's and C&C Gleeson brands, the Group supplies over 35,000 pubs, bars, restaurants and hotels, and is a key route-to-market for major international beverage companies.

Β·; C&C Group also has a minority investment in the Admiral Taverns tenanted pub group, which owns over 800 pubs across England & Wales and exports its Magners and Tennent's brands to over 60 countries worldwide.

C&C Group is headquartered in Dublin and is listed on the London Stock Exchange.

Contacts

C&C Group plcPatrick McMahon | Group Strategy DirectorTel: +353 86 389 0007Email:patrick.mcmahon@candcgroup.ie

FTI ConsultingJonathan Neilan/Paddy BerkeryTel: +353 1 765 0886Email:CandCGroup@fticonsulting.com

Novella CommunicationsTim RobertsonTel: +44 203 151 7008Email:TimR@novella-comms.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCBXBDGSUDBGCX
Date   Source Headline
8th Aug 20247:36 amRNSAGM Update and Cooperation Agreement
31st Jul 202412:01 pmRNSResponse to Shareholder Letter
23rd Jul 202410:00 amRNSDirector/PDMR Shareholding
18th Jul 20245:16 pmRNSDirector/PDMR Shareholding
17th Jul 20242:40 pmRNSNotice of AGM
11th Jul 20244:45 pmRNSDirectorate Changes
5th Jul 20242:50 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSAnnual Financial Report
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSTransaction in Own Shares
25th Jun 20247:00 amRNSTransaction in Own Shares
24th Jun 20241:52 pmRNSResponse to Shareholder Letter
24th Jun 20247:00 amRNSTransaction in Own Shares
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 20247:00 amRNSTransaction in Own Shares
19th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20247:00 amRNSTransaction in Own Shares
17th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 20249:45 amRNSHolding(s) in Company
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSPY Accounting Adjustments and Directorate Changes
7th Jun 20247:00 amRNSSummary of FY2024 Unaudited Financial Performance
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20244:45 pmRNSNotice of Results
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20243:00 pmRNSBlock listing Interim Review
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20244:15 pmRNSTotal Voting Rights
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
30th May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares
22nd May 20244:48 pmRNSBoard Committee Changes
22nd May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSTransaction in Own Shares
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
15th May 20245:50 pmRNSDirector/PDMR Shareholding
15th May 20247:00 amRNSHolding(s) in Company
15th May 20247:00 amRNSTransaction in Own Shares
14th May 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.